Eventide Asset Management »

Cytokinetics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 254k 52.80
2024-06-30 $14M 254k 54.18
2024-03-31 $18M 254k 70.11
2023-12-31 $46M 556k 83.49
2023-09-30 $16M 556k 29.46
2023-06-30 $18M 556k 32.62
2023-03-31 $20M 556k 35.19
2022-12-31 $26M 556k 45.82